These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1913620)

  • 21. Biochemical and biological studies on 2-desamino-2-methylaminopterin, an antifolate the polyglutamates of which are more potent than the monoglutamate against three key enzymes of folate metabolism.
    Rosowsky A; Galivan J; Beardsley GP; Bader H; O'Connor BM; Russello O; Moroson BA; DeYarman MT; Kerwar SS; Freisheim JH
    Cancer Res; 1992 Apr; 52(8):2148-55. PubMed ID: 1313737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A phase I evaluation of the quinazoline antifolate thymidylate synthase inhibitor, N10-propargyl-5,8-dideazafolic acid, CB3717.
    Calvert AH; Alison DL; Harland SJ; Robinson BA; Jackman AL; Jones TR; Newell DR; Siddik ZH; Wiltshaw E; McElwain TJ
    J Clin Oncol; 1986 Aug; 4(8):1245-52. PubMed ID: 3734849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of prostaglandin E2 in ornithine decarboxylase induction by a tumor-promoting agent, 7-bromomethylbenz[a]anthracene, in mouse epidermis.
    Yamamoto S; Jiang H; Otsuka C; Kato R
    Carcinogenesis; 1992 May; 13(5):905-6. PubMed ID: 1587007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuronal regulation of ornithine decarboxylase induced by androgens in the mouse kidney.
    Tovar A; Peñuela A; Sánchez-Capelo A; Monserrat F; Cremades A; Peñafiel R
    Gen Pharmacol; 1995 Sep; 26(5):997-1001. PubMed ID: 7557274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Catecholamines are required for testosterone induction of ornithine decarboxylase in the mouse kidney.
    Cremades A; Tovar A; Peñafiel R
    Biochem Int; 1992 Aug; 27(5):823-30. PubMed ID: 1417915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II study of the antifolate N10-propargyl-5,8-dideazafolic acid (CB 3717) in advanced breast cancer.
    Cantwell BM; Macaulay V; Harris AL; Kaye SB; Smith IE; Milsted RA; Calvert AH
    Eur J Cancer Clin Oncol; 1988 Apr; 24(4):733-6. PubMed ID: 3383974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The duration of the inhibition of thymidylate synthase in intact L1210 cells exposed to two different classes of quinazoline analogues.
    Kimbell R; Jackman AL; Boyle FT; Hardcastle A; Aherne W
    Adv Exp Med Biol; 1993; 338():597-600. PubMed ID: 8304189
    [No Abstract]   [Full Text] [Related]  

  • 28. The clinical pharmacokinetics of the novel antifolate N10-propargyl-5,8-dideazafolic acid (CB 3717).
    Alison DL; Newell DR; Sessa C; Harland SJ; Hart LI; Harrap KR; Calvert AH
    Cancer Chemother Pharmacol; 1985; 14(3):265-71. PubMed ID: 3995686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of hepatic and renal ornithine decarboxylase by cadmium in rats.
    Yoshida T; Numazawa S; Kuroiwa Y
    Biochem Biophys Res Commun; 1984 Dec; 125(3):882-7. PubMed ID: 6517942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple membrane transport systems for the uptake of folate-based thymidylate synthase inhibitors.
    Jansen G; Schornagel JH; Westerhof GR; Rijksen G; Newell DR; Jackman AL
    Cancer Res; 1990 Dec; 50(23):7544-8. PubMed ID: 2253202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent preclinical and clinical studies with the thymidylate synthase inhibitor N10-propargyl-5,8-dideazafolic acid (CB 3717).
    Calvert AH; Newell DR; Jackman AL; Gumbrell LA; Sikora E; Grzelakowska-Sztabert B; Bishop JA; Judson IR; Harland SJ; Harrap KR
    NCI Monogr; 1987; (5):213-8. PubMed ID: 3431591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Folate analogues. 30. Synthesis and biological evaluation of N10-propargyl-5,8-dideaza-5,6,7,8-tetrahydrofolic acid and related compounds.
    Nair MG; Dhawan R; Ghazala M; Kalman TI; Ferone R; Gaumont Y; Kisliuk RL
    J Med Chem; 1987 Jul; 30(7):1256-61. PubMed ID: 3599032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postnatal exposure to androgens alters renal ornithine decarboxylase ontogeny and abolishes renal sexual dimorphism in mice.
    Sánchez-Capelo A; Tejada F; Ruzafa C; Cremades A; Peñafiel R
    Biol Neonate; 1999 Aug; 76(2):72-83. PubMed ID: 10393991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dietary induction of ornithine decarboxylase in male mouse kidney.
    Suka M; Matsufuji S; Murakami Y
    Biochim Biophys Acta; 1999 Nov; 1472(3):455-61. PubMed ID: 10564759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Staurosporine, a potent protein kinase C inhibitor, augments phorbol ester-caused ornithine decarboxylase induction in mouse epidermis.
    Jiang H; Yamamoto S; Kato R
    Carcinogenesis; 1992 Mar; 13(3):355-9. PubMed ID: 1547524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation of structure and rate of synthesis of ornithine decarboxylase protein in mouse kidney.
    Persson L; Seely JE; Pegg AE
    Biochemistry; 1984 Jul; 23(16):3777-83. PubMed ID: 6477895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of hepatic and renal ornithine decarboxylase by cobalt and other metal ions in rats.
    Yoshida T; Numazawa S; Kuroiwa Y
    Biochem J; 1986 Jan; 233(2):577-81. PubMed ID: 3754136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toxicologic studies of the 2,4-diamino-quinazoline antifolate, methasquin (NSC-122870).
    Philips FS; Sternberg SS; Sodergren JE; Vidal P
    Cancer Chemother Rep; 1971 Feb; 55(1):35-42. PubMed ID: 5001089
    [No Abstract]   [Full Text] [Related]  

  • 39. Phase II study of a novel antifolate, N10-propargyl-5,8 dideazafolic acid (CB3717), in malignant mesothelioma.
    Cantwell BM; Earnshaw M; Harris AL
    Cancer Treat Rep; 1986 Nov; 70(11):1335-6. PubMed ID: 3768876
    [No Abstract]   [Full Text] [Related]  

  • 40. Influence of the antifolate drug Methotrexate on the development of murine neural tube defects and genomic instability.
    Zhao J; Guan T; Wang J; Xiang Q; Wang M; Wang X; Guan Z; Xie Q; Niu B; Zhang T
    J Appl Toxicol; 2013 Sep; 33(9):915-23. PubMed ID: 22806879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.